Two Sigma Investments, LP Tg Therapeutics, Inc. Transaction History
Two Sigma Investments, LP
- $42.8 Billion
- Q1 2025
A detailed history of Two Sigma Investments, LP transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 793,639 shares of TGTX stock, worth $28.8 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
793,639
Previous 606,208
30.92%
Holding current value
$28.8 Million
Previous $18.2 Million
71.51%
% of portfolio
0.07%
Previous 0.04%
Shares
24 transactions
Others Institutions Holding TGTX
# of Institutions
411Shares Held
88MCall Options Held
2.34MPut Options Held
2.01M-
Vanguard Group Inc Valley Forge, PA15.6MShares$566 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$413 Million0.0% of portfolio
-
State Street Corp Boston, MA7.43MShares$270 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.28MShares$119 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.85MShares$103 Million9.29% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.27B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...